Toshiba manufactures milestone 1000th 320-row area detector CT, Aquilion ONE. ViSION FIRST Edition
Otawara, Japan, July 1st, 2015 — achieving a significant milestone in the advancement of computed tomography (CT) in the practice of diagnostic imaging, Toshiba Medical Systems Co., Ltd. (Headquarters: Tochigi Prefecture Otawara President: Takiguchi Toshio) announced the production of the 1000th Aquilion ONE™, launched in 2007 as the world’s first 320-row area detector CT, able to scan 16cm at once.
The memorable 1000th Aquilion ONE will be shipped to the new Royal Adelaide Hospital (RAH) which is located in South Australia State, Australia and is scheduled to open in April 2016. The new RAH will be one of the most technologically advanced hospitals in Australia. “We are extremely pleased to be able to support the RAH’s vision of delivering the highest levels of patient care by providing state-of-the-art diagnostic imaging technology such as the Aquilion ONE ViSION Edition.” said Rob Walczynski, National CT Manager, Toshiba Australia,
Aquilion ONE was introduced at the Radiological Society of North America in November 2007, and immediately drew worldwide attention as a CT that can scan a whole organ such as the heart or brain in one rotation with a 16cm detector which consists of 320 rows of the industry’s finest 0.5 mm detector elements. This dynamic volume CT system has revolutionized the use of CT, not just for morphology, but also for dynamic and functional diagnosis. These new applications have been developed in close collaboration with clinicians from all over the world.
Aquilion ONE has evolved into a system employing the latest dose reduction techniques such as Adaptive Iterative Dose Reduction 3D (AIDR 3D) and cutting edge technology in the PUREVision detector, the latest ViSION edition includes faster rotation speed of 275ms, and state of the art applications. With these features, the Aquilion ONE series is installed in leading institutions in many countries, which has resulted in shipment of 1000 systems. State-of-the-art technology developed for Aquilion ONE has migrated to the entire CT line-up including Aquilion™ PRIME, Aquilion Lightning™ and Alexion™ systems. In particular, AIDR 3D is now a standard feature on the entire Toshiba CT range because Toshiba believes that dose reduction should not be an option.
State-of-the-art technology developed for Aquilion ONE has migrated to the entire CT line-up including Aquilion™ PRIME, Aquilion Lightning™ and Alexion™ systems. In particular, AIDR 3D is now a standard feature on the entire Toshiba CT range because Toshiba believes that dose reduction should not be an option.
This year Toshiba CT will celebrate 40 years of business. Toshiba will continue to provide solutions that improve the quality and efficiency of medical care for all patients.
Aquilion, Aquilion ONE, ViSION Edition, Aquilion Lightning, Alexion are trademarks of Toshiba Medical systems Corporation.
About Toshiba of Canada Limited, Medical Systems Division
With headquarters in Markham, Ontario, Toshiba of Canada Limited, Medical Systems Division (TCL), markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in Canada. For more information, visit the TCL Medical Systems Division website at www.toshiba-medical.ca
About Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation’s website at www.toshibamedicalsystems.com.
Toshiba Corporation, a Fortune 500 company, channels world-class capabilities in advanced electronic and electrical products and systems into five strategic business domains: Energy & Infrastructure, Community Solutions, Healthcare Systems & Services, Electronic Devices & Components, and Lifestyles Products & Services. Guided by the principles of The Basic Commitment of the Toshiba Group, “Committed to People, Committed to the Future,” Toshiba promotes global operations towards securing “Growth Through Creativity and Innovation” and is contributing to the achievement of a world in which people everywhere live in a safe, secure and comfortable society. Founded in Tokyo in 1875, today’s Toshiba is at the heart of a global network of over 590 consolidated companies employing over 200,000 people worldwide, with annual sales surpassing 6.5 trillion yen (US$63 billion). To find out more about Toshiba, visit www.toshiba.co.jp/index.htm.
For additional information, contact the Medical Systems Division at firstname.lastname@example.org